Colgate Palmolive (CL) Stock May Trade At A 31% Discount To Fair Value

Colgate-Palmolive has delivered a solid 30.8% gain over the past three years, yet its valuation signals pull in different directions, with an intrinsic value estimate pointing to upside while market multiples lean the other way. For investors, the contrast raises questions about whether the current US$88.41 share price reflects the cash flows of this household products giant or the premium attached to its steady profile.

• A 30.8% return over three years suggests Colgate-Palmolive has rewarded patient shareholders, which can make fresh entry points tougher to judge.
• Resilient demand for everyday oral care and hygiene products can support future cash generation, while any sustained pressure on input costs or pricing power may weigh on margins and the valuation case.
• The broader checks are cautious, with Colgate-Palmolive scoring only 2 out of 6 on value, which leans expensive even though the Discounted Cash Flow (DCF) estimate suggests the stock trades about 31% below intrinsic value.

The issue now is whether Colgate-Palmolive's share price is closer to the richer view implied by market multiples or the discount suggested by the intrinsic value estimate.

Scan beyond Colgate-Palmolive and compare its mixed valuation signals with 49 high quality undervalued stocks, which pairs resilient cash flows with balance sheets built to handle tougher conditions.

Is Colgate-Palmolive Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) model here hinges on how much cash Colgate-Palmolive can keep pulling in and return to shareholders over time. On the latest twelve-month numbers, the group generated about $3.85b in free cash flow in reporting-currency terms, which sets a solid base for a business built around everyday consumer staples.

Analysts and internal estimates used in this DCF point to growing free cash flow over the next decade, rather than a sharp ramp up or a structural decline. Feeding those projections into the 2 Stage Free Cash Flow to Equity framework produces an intrinsic value estimate of about $128 per share. At the current $88.41 price, that implies the stock trades at roughly a 31.0% discount to the cash flows used in the model. On this method, Colgate-Palmolive appears undervalued.

On the DCF numbers alone, Colgate-Palmolive screens as undervalued relative to its current share price.

Our Discounted Cash Flow (DCF) analysis suggests Colgate-Palmolive is undervalued by 31.0%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Colgate-Palmolive.

Does Colgate-Palmolive Look Pricey on Earnings?

For a mature consumer staples group like Colgate-Palmolive, the P/E ratio is a straightforward way to see how much investors are paying for each dollar of earnings.

On this yardstick, the stock looks full. Colgate-Palmolive trades on a P/E of about 34.6x, which is well above the Household Products industry average of 16.9x and ahead of the peer set near 22.8x. A more tailored fair P/E for the business, which blends its sector, profitability profile, size and risk factors, sits around 24.0x. That is meaningfully lower than where the shares change hands today and points to a rich earnings multiple even after adjusting for the quality of the franchise.

On the P/E measure, Colgate-Palmolive stock currently appears expensive relative to both its sector and a more customised fair multiple.

See what the numbers say about this price — find out in our valuation breakdown.

The Colgate-Palmolive Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Colgate-Palmolive pick up where this valuation split leaves off by spelling out which earnings paths, margin shapes and balance of risks would need to hold for today’s market price to look high or low. Each narrative links its implied figure to a specific view on how Colgate-Palmolive's growth profile, profitability and risk picture could evolve, giving you a reference point to revisit as fresh information comes through the Community page.

Community views on Colgate-Palmolive pull in opposite directions, from cost driven upside to questions about how much of the story is already in the price.

Bull case: 11% undervalued

"Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll-out of complementary products across 75 markets, are set to capture increased value from emerging middle-class consumers and rising health/hygiene awareness globally, supporting top-line organic sales acceleration and improved pricing power…"

Read the full Bull Case to see why Colgate-Palmolive could be undervalued

Bear case: roughly fairly valued

"This creates a trap worth naming. If you normalise the margin but leave the future multiple at the GAAP-derived figure, you count the adjustment twice and overstate fair value by roughly 45%…"

Read the full Bear Case to see why Colgate-Palmolive could be overvalued

Do you think there's more to the story for Colgate-Palmolive? Head over to our Community to see what others are saying!

The Bottom Line

Colgate-Palmolive’s Discounted Cash Flow (DCF) work points to meaningful upside from the current price, while the P/E view flags an overvalued stock on earnings compared with peers. That tension reflects a simple split: the intrinsic value model leans on the durability of future cash flows and modest funding needs, while the multiple view is anchored in what investors are willing to pay today for those earnings. With broader valuation checks still weak, the debate now hinges on one question: Do margins and pricing power hold well enough for cash generation to win out over a stretched earnings multiple?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com